The vaccine, known as CoronaVac, is still in phase 3 clinical trials in Brazil and has not been registered for wider use in Brazil, Anvisa said.
Brazil health auth. OKs import of 6 mln doses of Chinese COVID-19 vaccine
By REUTERS
05/03/2024 06:06 AM
By REUTERS
05/03/2024 04:08 AM
By REUTERS
05/03/2024 03:21 AM
By REUTERS
05/03/2024 12:13 AM
By REUTERS
05/02/2024 09:01 PM
By DR. ITAI GAL
05/02/2024 08:30 PM
By REUTERS
05/02/2024 06:49 PM
By REUTERS
05/02/2024 05:27 PM
By REUTERS
05/02/2024 04:49 PM